Prognostic value of prostate volume in non-muscle invasive bladder cancer
Abstract There is evidence that a history of benign prostatic hyperplasia increases the incidence of bladder cancer, and treatment with 5-alpha reductase inhibitor or androgen deprivation therapy reduces recurrence of non-muscle invasive bladder cancer. We aimed to evaluate whether prostate volume a...
Guardado en:
Autores principales: | Won Sik Ham, Jee Soo Park, Won Sik Jang, Young Deuk Choi, Jongchan Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a2f8c1b853e0440ba848a6d93098b682 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Revisiting extraprostatic extension based on invasion depth and number for new algorithm for substaging of pT3a prostate cancer
por: Cheol Keun Park, et al.
Publicado: (2021) -
Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients
por: Bum Sik Tae, et al.
Publicado: (2017) -
Prognostic value of preoperative neutrophil-to-lymphocyte ratio in histological variants of non-muscle-invasive bladder cancer
por: Deng-xiong Li, et al.
Publicado: (2021) -
Clinical significance of multiparametric MRI and PSA density as predictors of residual tumor (pT0) following radical prostatectomy for T1a-T1b (incidental) prostate cancer.
por: Doo Yong Chung, et al.
Publicado: (2018) -
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
por: Sia Viborg Lindskrog, et al.
Publicado: (2021)